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Summary
Congenital nystagmus (CN) is a common oculomotor
disorder (frequency of 1/1,500 live births) characterized
by bilateral uncontrollable ocular oscillations, with on-
set typically at birth or within the first few months of
life. This condition is regarded as idiopathic, after ex-
clusion of nervous and ocular diseases. X-linked, au-
tosomal dominant, and autosomal recessive modes of
inheritance have been reported, but X-linked inheritance
is probably the most common. In this article, we report
the mapping of a gene for X-linked dominant CN
(NYS1) to the short arm of chromosome X, by showing
close linkage of NYS1 to polymorphic markers on chro-
mosome Xp11.4-p11.3 (maximum LOD score of 3.20,
over locus DXS993). Because no candidate gene, by vir-
tue of its function, has been found in this region of
chromosome Xp, further studies are required, to reduce
the genetic interval encompassing the NYS1 gene. It is
hoped that the complete gene characterization will ad-
dress the complex pathophysiology of CN.
Introduction
Congenital nystagmus (CN) is a relatively common oc-
ulomotor disorder that has an estimated frequency of 1/
1,500 live births, based on a population study of school
children in Sweden (Forssman and Ringner 1971). It is
an involuntary, bilateral, often symmetric, invariably
conjugated, and predominantly horizontal ocular oscil-
lation that is present at birth or that develops within the
first few months of life. The rapid to-and-fro oscillations
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of the eyes produce corresponding oscillations of images
on the retina, so that both visual acuity and contrast
sensitivity are expected to be severely impaired. In pa-
tients with idiopathic CN (ICN), however, visual acuity
usually is only moderately impaired, a feature that con-
trasts with the variable degree of visual loss observed in
nystagmus due to primary ophthalmological disorders.
Indeed, CN also can occur in association with various
manifestations, such as strabismus and head or posture
nystagmus.
CN has been divided into sensory and motor types
(Kestenbaum 1961, p. 356; Forssman 1964; Cogan
1967; Harcourt 1970; Wybar 1972; Gelbart and Hoyt
1988). The sensory type is ascribed to patent visual-
pathway diseases, including strabismus, aniridia, cata-
racts, and coloboma, or to recognizable conditions (e.g.,
Leber congenital amaurosis, optic nerve hypoplasia or
atrophy, ocular or oculocutaneous albinism, retinos-
chisis, achromatopsia, and X-linked congenital station-
ary night blindness). For the motor type, all known dis-
eases are excluded, and ICN usually is observed in
children with no eye or CNS anomaly.
Various patterns of inheritance have been described
for ICN, including X-linked dominant and X-linked re-
cessive (MIM 310700), autosomal dominant (MIM
164100), and autosomal recessive (MIM 257400) in-
heritances. X-linked inheritance with incomplete pene-
trance and variable expressivity is probably the most
common. In 1996, a gene for autosomal dominant CN
was mapped to chromosome 6p12 (Kerrison et al.
1996), but no chromosomal mapping for X-linked nys-
tagmus has been reported thus far. In this article, we
report the first mapping of a gene for X-linked ICN, to
chromosome Xp11.4-p11.3.
Patients and Methods
Patients
One large French family—including 12 individuals
with ICN (7 female and 5 male, of whom only 3 were
available), over four generations, and 10 healthy rela-
tives—was recruited (fig. 1). Inclusion criteria were nys-
Figure 1 Haplotype analyses of X-linked dominant ICN. Blackened regions of haplotypes indicate linkage between the markers and the disease.
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Table 1
Pairwise Linkage Between NYS1 and 11 Polymorphic DNA Markers
of the Xp Chromosome
LOCUS MARKER
LOD SCORE AT v 
Zmax vmax.00 .05 .10 .20 .30
DXS1068 AFM200ye7  1.02 1.16 1.10 .86 1.16 .10
DXS8015 AFMa130yb1  .81 .96 .93 .72 .97 .15
DXS8012 AFMa124xd9 3.13 2.89 2.64 2.09 1.48 3.13 .00
DXS993 AFM203wf4 3.13 2.89 2.64 2.09 1.48 3.13 .00
DXS1201 AFM256ze5 1.86 1.71 1.55 1.2 .84 1.86 .00
DXS8035 AFMa246ze9 3.13 2.89 2.64 2.09 1.48 3.13 .00
DXS8080 AFMc012zc1 2.74 2.54 2.33 1.86 1.33 2.74 .00
DXS8054 AFMb291yc9 2.74 2.54 2.33 1.86 1.33 2.74 .00
DXS8083 AFMc024xc5 .20 .17 .14 .08 .04 .20 .00
DXS1003 AFM276xf5  .32 .12 .36 .32 .36 .20
DXS1055 AFM168ya3  .02 .42 .66 .59 .66 .20
Figure 2 Support for location of an X-linked ICN gene, with
respect to three chromosome Xp markers. Likelihood estimates are
given in log10. Distances between marker loci, in centimorgans, are
shown along the X-axis. The maximum location score for NYS1 is
between DXS8015 and DXS1003, over the locus DXS993.
tagmus recorded at birth or within the 1st year of life
and exclusion of recognizable abnormalities of the oc-
ular or neural visual pathway, by detailed clinical studies
including visual acuity, fundus aspect, visual field, and
color vision testing, electroretinography, and visual-
evoked potentials. X-linked dominant inheritance with
incomplete penetrance is the most probable mode of
inheritance, as indicated by no male-to-male transmis-
sion but frequent male-to-female transmission; several
apparently unaffected girls (V-9, V-16, and V-17) were
born to affected men, and several apparently unaffected
women (III-3, IV-5, and IV-10) passed the disease to the
next generation. The penetrance of the disease appar-
ently did not change with age (fig. 1).
DNA Analysis
Blood samples (20 ml) were obtained, with informed
consent, from the family members, and DNA was pre-
pared from lymphocyte pellets by use of SDS lysis,
proteinase K digestion, phenol/chloroform extraction,
ethanol precipitation, and Tris-EDTA resuspension.
Hypervariable microsatellites developed by Dib et al.
(1996) were used for genotyping by PCR. Genomic
DNA (200 ng) was amplified by use of 0.5 U Taq poly-
merase (Life Technologies), in the recommended buffer
(1.5 mM MgCl2, 20 mM each deoxynucleotide, and 20
mM primers in a final volume of 20 ml). Amplification
conditions were 95C for 10 min, followed by 30 cycles
at 94C for 30 s, 55C for 30 s, and 72C for 30 s and
a final extension at 72C for 10 min. PCR products were
incubated at 94C for 5 min before loading (3 ml) on a
6%-acrylamide, 7.5 M–urea gel. Electrophoresis was
performed at 1,400 V, 65 W at 50C for 3 h. The gels
were blotted onto nylon membranes (Appligene), labeled
by chemiluminescence according to the manufacter’s in-
structions (enhanced-chemiluminescence direct nucleic
acid labeling and detection systems; Amersham Life Sci-
ence), and exposed to x-ray films for 10 min.
Linkage Analysis
Markers containing short tracts of (CA)n repeats were
chosen from the Ge´ne´thon linkage map, on the basis of
their informativity, and had an average recombination
fraction (v) of .02. All nucleotide sequences are avail-
able in the Genome Database. NYS1 was tested under
the assumption that the disease is transmitted as an X-
linked dominant trait with penetrances of 1.00 and .60
in males and females, respectively (fig. 1).
Two-point LOD scores for linkage betweenNYS1 and
each microsatellite DNA marker were calculated by use
of the MLINK option of the LINKAGE program, ver-
sion 5.1 (Lathrop et al. 1985). Multipoint LOD-score
analysis (LINKMAP program; Lathrop et al. 1985) was
used to estimate the position of NYS1 with respect to
the intervals on the following genetic map (genetic
distance between adjacent loci in parentheses): pter–
DXS1068–(2.2 cM)–DXS8015–(7.7 cM)–DXS993–
(0.0 cM)–DXS8012–(2.1 cM)–DXS1201–(0.0 cM)–
DXS8035–(2.0 cM)–DXS8080–(1.4 cM)–DXS8054–
(1.4 cM)–DXS8083–(2.1 cM)–DXS8026–(1.9 cM)–
DXS1003–(0.9 cM)–DXS1055–cen (Dib et al. 1996). In
this procedure, the map of the marker loci is fixed, and
the position of the disease locus varies throughout the
map.
X-Inactivation Assay
Genomic DNA (500 ng) was incubated overnight with
or without the restriction enzyme HpaII, in the buffer
supplied by the manufacturer and in a total volume of
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Table 2
Summary of Key Recombination Events Involving NYS1 and Xp Probes
INDIVIDUAL PHENOTYPE
SEX OF
PARENT
STUDIED
RECOMBINATION EVENT
DXS1058 DXS8015 DXS993 DXS1003 DXS1055
III-5 AF F     
IV-11 AM F     
V-15 HM F     
NOTE.—A plus sign () indicates presence of a recombination event, and a minus sign () indicates
absence of a recombination event. AM  affected male, AF  affected female, HM  healthy male,
and F  female.
Figure 3 X-inactivation patterns of the informative females in
the family studied. The different alleles at the X androgen-receptor
locus are shown (arrowheads labeled A–F). D  DNA digested by
HpaII, and UD  undigested DNA.
20 ml. One in two dilutions with water were made, and
1.5 ml was used in a PCR reaction to amplify the poly-
morphic glutamine repeat of the androgen-receptor lo-
cus, by use of primers HARA1 and HARA2, at an an-
nealing temperature of 60C (Allen et al. 1992). Products
were denatured in formamide-loading dye, and the single
strands were separated on 1-mm–thick 8%-polyacryl-
amide denaturing gels containing 7-M urea and 1# Tris
borate–EDTA. The gels were run for 3 h at a constant
40 mA and then were silver stained as described by Jouet
et al. (1994). A sample from a male control was used
to assess the completion of HpaII digestion of DNA.
Results
We generated an exclusion map of the X chromosome,
starting from the telomeric end of the short arm, and
found evidence for linkage of the disease gene (NYS1)
to the DXS993 locus on chromosome Xp11.4 (table 1).
Additional markers in the region were typed and also
gave positive pairwise LOD scores (table 1). The max-
imum pairwise LOD score (Zmax), with no recombination
event, was found at loci DXS993, DXS8012, and
DXS8035 ( at , for all three markers;Z  3.13 v  .00max
table 1). Multipoint linkage analyses were performed to
estimate the best position of NYS1. Figure 2 shows that
the maximum likelihood estimate for the location of
NYS1 was over the DXS993 locus ( ). TheZ  3.20max
odds against alternative orders were 11,000:1 in all
cases.
Haplotype analyses supplemented the multipoint
analysis by providing direct evidence for recombination
events (fig. 1 and table 2). With respect to the marker
loci, all haplotypes were resolved with a maximum of
one recombination event. The positioning of recombi-
nation events by this method was consistent with the
placement of NYS1 between DXS8015 and DXS1003.
In the X-inactivation studies, individuals IV-2 and
V-1, who do not carry the affected haplotype, displayed
a random X-inactivation pattern (fig. 3). Conversely, in-
dividuals III-3, III-5, IV-5, IV-10, IV-15, and V-3, who
do carry the affected haplotype, showed a skewed X-
inactivation pattern of either the affected haplotype
(III-3, III-5, IV-10, and IV-5) or the unaffected haplotype
(IV-5 and V-3) (fig. 3). Finally, individuals V-11, V-12,
and V-13 were not informative.
Discussion
We report here the mapping of a gene causing CN to
the short arm of chromosome X, owing to close linkage
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Figure 4 Ocular disease loci and genes (italicized) on chromo-
some Xp. OA1  ocular albinism; RP2, RP3, RP6, and RP15  X-
linked retinitis pigmentosa; CSNBX1 and CSNBX2  X-linked con-
genital stationary night blindness; COD1  X-linked cone dystrophy;
AIED  Aland island eye disease; OPA2  X-linked optic atrophy;
NDP  Norrie disease protein; EVR2  exudative vitreoretinopathy;
CACNA1F  calcium channel a1-subunit; and RPGR  retinitis pig-
mentosa GTPase regulator.
to eight highly polymorphic markers on Xp11.4-11.3.
This study supports the localization of the disease-caus-
ing gene in the 18.6-cM genetic interval defined by loci
DXS8015 and DXS1003. It is worth noting that the two
females who do not carry the affected haplotype dis-
played a random X-inactivation pattern, whereas all fe-
males who do carry the mutated gene displayed a skewed
X-inactivation pattern of either the affected or the un-
affected haplotype. Nevertheless, we did not observe any
correlation between the X-inactivation pattern and phe-
notype, strongly suggesting that NYS1 is transmitted as
an X-linked dominant trait with incomplete penetrance
in females. The question of whether genetic heteroge-
neity exists in X-linked CN remains open to debate,
especially since some reported pedigrees are consistent
with strict X-linked recessive inheritance, with no ex-
pression in females (Forssman and Ringner 1971).
Interestingly, NYS1 maps to the genetic interval en-
compassing the genes for congenital stationary night
blindness (CSNB1, Xp11.4-p11.3), retinitis pigmentosa
(RP2, Xp11.3), cone dystrophy (COD1, Xp11.4), Nor-
rie disease protein (NDP, Xp11.4), exsudative vitreoreti-
nopathy (EVR2, Xp11.4), Aland island eye disease
(AIED, Xp11.4-p11.23), and X-linked optic atrophy
(OPA2, Xp11.4-p11.21) (Genatlas; see fig. 4). This ob-
servation raises the question of whether ICN is allelic
to one of these oculopathies. Yet, the striking differences
in clinical profile and evolution suggest that ICN is in-
deed a genetically distinct entity.
No candidate gene, by virtue of its function, has been
found in the Xp region encompassing the NYS1 gene,
but several observations support the view that a neural-
defect gene underlies the disease—namely, (1) a high
frequency of afferent visual-pathway dysfunctions, (2)
CN damping by use of contact lenses and cutaneous
stimulation of the trigeminal nerve, (3) the presence of
a null zone, (4) neurological origin of acquired nystag-
mus in adults, and (5) requirement of a functioning (even
leaky) geniculostriate system for the development of
horizontal CN. However, the search for an identifiable
neuroanatomic substrate is difficult, since nystagmus
probably results from instability of the ocular motor
system, rather than from a precise defect in a neurolog-
ical or visual pathway (Dell’Osso et al. 1974).
Several hypotheses concerning the origin of CN have
been ruled out, including the presence of a leaky neural
integrator (Dell’Osso et al. 1993), misdirection of the
retinogeniculate or subcortical visual pathway (Fielder
and Evans 1988), and albino-like abnormal chiasmatic
decussation of the optic axons (Apkarian and Shallo-
Hoffman 1991). Indeed, recent studies by Dell’Osso et
al. (1992a, 1992b, 1992c) showed that CN patients had
intense fixation reflexes and stable pursuing eye move-
ments with normal vestibulo-ocular reflexes (ocular-sta-
bilization systems) and proposed that CN was caused
by unstable efferent impulses from the extraocular mus-
cles. Ultrastructural studies support the disorganization
of the architecture of the extraocular muscles, with de-
generative changes of the mitochondria in CN patients
(Adachi et al. 1973; Pepin et al. 1980; Mencucci et al.
1995; Peng et al. 1998). Yet, it also has been suggested
that the extraocular muscle changes are secondary to
nystagmus (Hamed 1995). Whatever the mechanism, it
is hoped that the identification of the NYS1 gene will
address the complex pathophysiology of CN.
Acknowledgment
This study was supported by the Retina France Association.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Genatlas, Infobiogen, http://www.Infobiogen.fr (for the local-
ization of CSNBX1 and CSNBX2, RP2, RP3, RP6, RP15,
COD1, NDP, EVR2, AIED, and OPA2)
1146 Am. J. Hum. Genet. 64:1141–1146, 1999
Ge´ne´thon, http://www.genethon.fr (for the genetic map of the
X chromosome)
Genome Database, http://gdbwww.gdb.org (for the nucleotide
sequences of markers)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for X-linked dominant and X-
linked recessive [MIM 310700], autosomal dominant [MIM
164100], and autosomal recessive [MIM 257400] CN)
References
Adachi M, Torii J, Volk BW, Briet P, Wolintz A, Scheck L
(1973) Electronmicroscopic and enzyme histochemical stud-
ies of cerebellum, ocular and skeletal muscles in chronic
progressive ophthalmoplegia with cerebellar ataxia. Acta
Neuropathol (Berl) 23:300–312
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont
JW (1992) Methylation of HpaII and HhaI sites near the
polymorphic CAG repeat in the human androgen-receptor
gene correlates with X chromosome inactivation. Am JHum
Genet 51:1229–1239
Apkarian P, Shallo-Hoffman J (1991) VEP projections in con-
genital nystagmus; VEP asymmetry in albinism: a compar-
ison study. Invest Ophthalmol Vis Sci 32:2653–2661
Cogan DG (1967) Congenital nystagmus. Can J Ophthalmol
2:4–10
Dell’Osso LF, Flynn JT, Daroff RB (1974) Hereditary congen-
ital nystagmus: an intrafamilial study. Arch Ophthalmol 92:
366–374
Dell’Osso LF, Vander Steen J, Steinman RM, Collewijn H
(1992a) Foveation dynamics in congenital nystagmus. I. Fix-
ation. Doc Ophthalmol 79:1–23
——— (1992b) Foveation dynamics in congenital nystagmus.
II. Smooth pursuit. Doc Ophthalmol 79:25–49
——— (1992c) Foveation dynamics in congenital nystagmus.
III. Vestibulo-ocular reflex. Doc Ophthalmol 79:51–70
Dell’Osso LF, Weissman BM, Leigh RJ, Abel LA, Sheth NV
(1993) Hereditary congenital nystagmus and gaze-holding
failure: the role of the neural integrator. Neurology 43:
1741–1749
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A,
Millasseau P, et al (1996) A comprehensive genetic map of
the human genome based on 5,264 microsatellites. Nature
380:152–154
Fielder AR, Evans MN (1988) Is the geniculostriate system a
prerequisite for nystagmus? Eye 2:628–635
Forssman B (1964) A study of congenital nystagmus. Acta
Otolaryngol (Stockh) 57:427–449
Forssman B, Ringner B (1971) Prevalence and inheritance of
congenital nystagmus in a Swedish population. Ann Hum
Genet 35:139–147
Gelbart SS, Hoyt CS (1988) Congenital nystagmus: a clinical
perspective in infancy. Graefes Arch Clin Exp Ophthalmol
226:178–180
Hamed LM (1995) Congenital nystagmus: fine structure of
human extraocular muscles. Surv Ophthalmol 40:250–251
Harcourt B (1970) Hereditary nystagmus in early childhood.
J Med Genet 7:253–256
Jouet M, Rosenthal A, Armstrong G, MacFarlane J, Stevenson
R, Paterson J, Metzenberg A, et al (1994) X-linked spastic
paraplegia (SPG1), MASA syndrome and X-linked hydro-
cephalus result from mutations in the L1 gene. Nat Genet
7:402–407
Kestenbaum A (1961) Clinical methods of neuro-ophthal-
mologic examination. Grune & Stratton, New York
Kerrison JB, Arnould VJ, Barmada MM, Koenekoop RK,
Schmeckpeper BJ, Maumenee IH (1996) A gene for auto-
somal dominant congenital nystagmus localizes to 6p12.
Genomics 33:523–526
Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus
linkage analysis in humans: detection of linkage and esti-
mation of recombination. Am J Hum Genet 37:482–498
Mencucci R, Domenici-Lombardo L, Cortesini L, Faussone-
Pellegrini MS, Salvi G (1995) Congenital nystagmus: fine
structure of human extraocular muscles. Ophthalmologica
209:1–6
Peng GH, Zhang C, Yang JC (1998) Ultrastructural study of
extraocular muscle in congenital nystagmus. Ophthalmo-
logica 212:1–4
Pepin B, Mikol J, Goldstein B, Aron JJ, Lebuisson DA (1980)
Familial mitochondrial myopathy with cataract. J Neurol
Sci 45:191–203
Wybar K (1972) Significance of nystagmus in suspected blind-
ness in infancy. Isr J Med Sci 8:1492–1495
